PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
31237033-7	2019	Zymosan mainly induced IL1beta release.	Zymosan	0-7	interleukin 1 beta	Homo sapiens	23-30	
25344730-10	2014	With zymosan, "flare" ASD-IS cells produced more IL-1beta than most control cells, despite spontaneous production of large amounts of IL-1ss.	Zymosan	5-12	interleukin 1 beta	Homo sapiens	49-57	
26769828-10	2015	Moreover, the TLR6, NO, iNOS, IL-1beta, MCP-1, and the keratinocyte chemoattractant (KC) levels significantly decreased in the zymosan-stimulated groups maintained in riboflavin-enriched medium.	Zymosan	127-134	interleukin 1 beta	Homo sapiens	30-38	
25344730-10	2014	With zymosan, "flare" ASD-IS cells produced more IL-1beta than most control cells, despite spontaneous production of large amounts of IL-1ss.	Zymosan	5-12	interleukin 1 beta	Homo sapiens	49-53	
22629855-2	2012	All of myelopeptides under examination in case of one-way introduction in cultures with zymosan demonstrated a decrease in zymosan-stimulated (1500 mkg/ml) production of IL-1beta, and activation of spontaneous production of this cytokine by whole blood cells.	Zymosan	88-95	interleukin 1 beta	Homo sapiens	170-178	
23507714-12	2013	Zymosan increased NLRP3 inflammasome and interleukin-1beta expression in glomus cells (p < 0.01).	Zymosan	0-7	interleukin 1 beta	Homo sapiens	41-58	
22629855-2	2012	All of myelopeptides under examination in case of one-way introduction in cultures with zymosan demonstrated a decrease in zymosan-stimulated (1500 mkg/ml) production of IL-1beta, and activation of spontaneous production of this cytokine by whole blood cells.	Zymosan	123-130	interleukin 1 beta	Homo sapiens	170-178	
21420486-5	2011	IFN-beta induced IL-27 expression by DC, and neutralisation of IL-27 abrogated the suppressive effects of IFN-beta on zymosan-induced IL-1 and IL-23 production and the generation of Th17 cells in vitro.	Zymosan	118-125	interleukin 1 beta	Homo sapiens	134-138	
19854233-9	2010	Bradykinin increased the zymosan-induced expression of TNF-alpha, and interleukin 1beta (IL-1beta) but did not affect the expression of interleukin 6 (IL-6) or interleukin 10 (IL-10).	Zymosan	25-32	interleukin 1 beta	Homo sapiens	70-87	
19854233-9	2010	Bradykinin increased the zymosan-induced expression of TNF-alpha, and interleukin 1beta (IL-1beta) but did not affect the expression of interleukin 6 (IL-6) or interleukin 10 (IL-10).	Zymosan	25-32	interleukin 1 beta	Homo sapiens	89-97	
19854233-11	2010	In contrast to the result in human glioma cells, bradykinin inhibits the zymosan-induced expression of TNF-alpha and IL-1beta in rat astrocytes, which shows a species-dependent manner.	Zymosan	73-80	interleukin 1 beta	Homo sapiens	117-125	
14973543-7	2004	An intra-articular injection of zymosan, 3 days after Ad5.IL-1/IL-6-Luc, increased Luc.	Zymosan	32-39	interleukin 1 beta	Homo sapiens	58-62	
9744647-4	1998	The combination of Fragmin and zymosan also induced significantly greater concentrations of IL-1beta (97+/-24) and TNFalpha (2.9+/-.8), but not IL-8 (2.0+/-15).	Zymosan	31-38	interleukin 1 beta	Homo sapiens	92-100	
8977210-6	1997	Furthermore, the addition of a TXA2 agonist, carbocyclic TXA2, to CI-treated monocytes dose-dependently restored the levels of TNF-alpha and IL-1beta synthesis to those found with serum-treated zymosan stimulation alone.	Zymosan	194-201	interleukin 1 beta	Homo sapiens	141-149	
2394035-4	1990	Zymosan stimulated monocytes to produce IL-1 but not IL-1 inhibitor.	Zymosan	0-7	interleukin 1 beta	Homo sapiens	40-44	
8025949-10	1994	PB-PMNs in culture also showed mRNA expression for IL-1 alpha, IL-1 beta, and TNF alpha in a time- and dose-dependent manner, especially after stimulation with zymosan.	Zymosan	160-167	interleukin 1 beta	Homo sapiens	63-72	
8066992-3	1994	Likewise, approximately 1000-fold less bovine IL-1 beta than human IL-1 beta was required to prime bovine neutrophils for an enhanced luminol-dependent chemiluminescence response to opsonized zymosan particles.	Zymosan	192-199	interleukin 1 beta	Homo sapiens	67-76